Elizabeth Celestin is a Pompano Beach, Florida based nurse practitioner. Active license number of Elizabeth Celestin is 11018987 in Florida. Her current practice location is 4 Ne 4th Ave, Pompano Beach. Patients can reach her at 754-222-6642 or can fax her at 954-943-1014. Elizabeth Celestin is APRN and her NPI number (Unique professional ID assigned by NPPES) is 1316680192. Elizabeth Celestin has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Elizabeth Celestin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1316680192
NPI Enumeration Date:
19 Apr, 2022
NPI Last Update On:
06 May, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elizabeth Celestin are as mentioned below.
License Number
Specialization
State
Status
11018987
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Elizabeth Celestin 2840 Sw 3rd St, Ft Lauderdale, Florida
Zip:
33312-2068
Phone Number:
786-718-7128
Patients can reach Elizabeth Celestin at 4 Ne 4th Ave, Pompano Beach, Florida or can call to book an appointment on 754-222-6642.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.